Little Green Pharma Ltd
ASX:LGP.AX
0.115 (AUD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 19.568 | 14.04 | 7.004 | 2.204 | 0.249 | 0.054 | 0 |
| Cost of Revenue
| 7.59 | 9.529 | 1.228 | 1.051 | 0.193 | 0.05 | 0.012 |
| Gross Profit
| 11.978 | 4.511 | 5.776 | 1.153 | 0.056 | 0.005 | -0.011 |
| Gross Profit Ratio
| 0.612 | 0.321 | 0.825 | 0.523 | 0.224 | 0.089 | -44.535 |
| Reseach & Development Expenses
| 6.595 | 7.22 | 1.78 | 1.005 | 0.373 | 0.376 | 0.024 |
| General & Administrative Expenses
| 4.662 | 17.165 | 3.517 | 2.202 | 3.546 | 0.794 | 0.043 |
| Selling & Marketing Expenses
| 3.512 | 4.835 | 2.11 | 1.455 | 0.646 | 1.145 | 0.138 |
| SG&A
| 8.173 | 25.661 | 5.626 | 3.657 | 4.367 | 1.939 | 0.182 |
| Other Expenses
| 2.746 | 0 | 3.267 | 4.086 | 0 | 0 | 0 |
| Operating Expenses
| 25.385 | 32.881 | 10.674 | 8.749 | 4.74 | 2.315 | 0.205 |
| Operating Income
| -7.628 | -28.371 | 24.695 | -8.988 | -4.684 | -2.365 | -0.217 |
| Operating Income Ratio
| -0.39 | -2.021 | 3.526 | -4.078 | -18.849 | -43.437 | -841.744 |
| Total Other Income Expenses Net
| 2.746 | 1.144 | -0.092 | -0.327 | -0.834 | -1.439 | 0 |
| Income Before Tax
| -8.557 | -27.227 | 24.604 | -9.315 | -5.518 | -3.804 | -0.217 |
| Income Before Tax Ratio
| -0.437 | -1.939 | 3.513 | -4.227 | -22.206 | -69.865 | -841.682 |
| Income Tax Expense
| 4.324 | -3.158 | 28.96 | -1.039 | -0 | -0.046 | 0 |
| Net Income
| -9.205 | -24.069 | -4.356 | -8.276 | -5.518 | -3.758 | -0.217 |
| Net Income Ratio
| -0.47 | -1.714 | -0.622 | -3.755 | -22.206 | -69.018 | -841.682 |
| EPS
| -0.037 | -0.1 | -0.026 | -0.065 | -0.041 | -0.028 | -0.002 |
| EPS Diluted
| -0.037 | -0.1 | -0.026 | -0.065 | -0.041 | -0.028 | -0.002 |
| EBITDA
| -4.643 | -27.032 | 25.38 | -8.802 | -4.59 | -2.315 | -0.205 |
| EBITDA Ratio
| -0.237 | -1.925 | 3.624 | -3.994 | -18.469 | -42.526 | -796.202 |